CNBX PHARMACEUTICALS INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2021-11-30 was $425.74K, a 1190.11% increase year-over-year.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2021-08-31 was $15.30K.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2021-05-31 was $27.13K, a 39.72% decline year-over-year.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for the quarter ending 2021-02-28 was $0.00, a 100.00% decline year-over-year.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2021 was $75.42K, a 4.58% increase from fiscal 2020.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2020 was $72.12K, a 92.92% decline from fiscal 2019.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2019 was $1.02M, a 10.08% increase from fiscal 2018.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, issued for services for fiscal 2018 was $925.39K, a 0.00% change from fiscal 2017.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-11-30 | $425.74K 10-Q · filed 2023-01-13 | $468.16K derived: sum of 4 quarters · filed 2023-01-13 |
| 2021-08-31 | $15.30K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-30 | $75.42K 10-K · filed 2022-11-30 |
| 2021-05-31 | $27.13K 10-Q · filed 2022-07-14 | $30.13K derived: sum of 4 quarters · filed 2022-07-14 |
| 2021-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-12 | $48.00K derived: sum of 4 quarters · filed 2022-04-12 |
| 2020-11-30 | $33.00K 10-Q · filed 2022-01-13 | $150.12K derived: sum of 4 quarters · filed 2022-01-13 |
| 2020-08-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $72.12K 10-K · filed 2021-11-29 |
| 2020-05-31 | $45.00K 10-Q · filed 2021-07-14 | |
| 2020-02-29 | $102.12K 10-Q · filed 2021-04-14 | |
| 2019-08-31 | $802.83K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $1.02M 10-K · filed 2020-11-04 |
| 2019-05-31 | $909.93K 10-Q · filed 2020-07-14 | |
| 2019-02-28 | $67.47K 10-Q · filed 2020-04-13 | |
| 2018-08-31 | $925.39K 10-K · filed 2019-11-29 | |
| 2017-08-31 | $925.39K 10-K · filed 2018-11-29 | |
| 2016-08-31 | $19.93K 10-K · filed 2017-12-08 | |
| 2015-08-31 | $83.12K 10-K · filed 2017-12-08 | |
| 2015-02-28 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-11-17 | |
| 2014-11-30 | $17.50K 10-Q/A · filed 2015-11-17 | |
| 2014-08-31 | $62.50K 10-K · filed 2016-01-07 |